Radiopharmaceutical developer Immunomedics has appointed Robert DeLuccia as CEO to take over duties previously handled by the company's founder, Dr. David Goldenberg. DeLuccia formerly served as marketing vice president at both Pfizer Laboratories and
Radiopharmaceutical developer Immunomedics has appointed Robert DeLuccia as CEO to take over duties previously handled by the company's founder, Dr. David Goldenberg. DeLuccia formerly served as marketing vice president at both Pfizer Laboratories and Winthrop Pharmaceuticals, as well as U.S. president of Sanofi Winthrop Pharmaceuticals.
DeLuccia will assume immediate management of the company, allowing Goldenberg to center his efforts on Immunomedics' cancer therapeutics research and other projects. DeLuccia's responsibilities will include developing strategies to best use the company's technology and personnel, according to the Morris Plains, NJ-based firm.
Immunomedics manufactures and distributes antibody-based cancer and infection imaging agents throughout the U.S. and Europe. Its products include CEA-Scan, for the detection of colorectal cancer, and LeukoScan, for the diagnosis of bone infection. LeukoScan is currently under review by the Food and Drug Administration.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.